These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11156553)

  • 1. Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity.
    Field MJ; Oles RJ; Singh L
    Br J Pharmacol; 2001 Jan; 132(1):1-4. PubMed ID: 11156553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents.
    Field MJ; Oles RJ; Lewis AS; McCleary S; Hughes J; Singh L
    Br J Pharmacol; 1997 Aug; 121(8):1513-22. PubMed ID: 9283683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytic-like activity of pregabalin in the Vogel conflict test in α2δ-1 (R217A) and α2δ-2 (R279A) mouse mutants.
    Lotarski SM; Donevan S; El-Kattan A; Osgood S; Poe J; Taylor CP; Offord J
    J Pharmacol Exp Ther; 2011 Aug; 338(2):615-21. PubMed ID: 21558437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive effect of pregabalin in septic shock-induced rectal hypersensitivity in rats.
    Eutamene H; Coelho AM; Theodorou V; Toulouse M; Chovet M; Doherty A; Fioramonti J; Bueno L
    J Pharmacol Exp Ther; 2000 Oct; 295(1):162-7. PubMed ID: 10991974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of pregabalin and analogues that target the alpha(2)-delta protein.
    Belliotti TR; Capiris T; Ekhato IV; Kinsora JJ; Field MJ; Heffner TG; Meltzer LT; Schwarz JB; Taylor CP; Thorpe AJ; Vartanian MG; Wise LD; Zhi-Su T; Weber ML; Wustrow DJ
    J Med Chem; 2005 Apr; 48(7):2294-307. PubMed ID: 15801823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregabalin: a new anxiolytic.
    Lauria-Horner BA; Pohl RB
    Expert Opin Investig Drugs; 2003 Apr; 12(4):663-72. PubMed ID: 12665421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin pharmacology and its relevance to clinical practice.
    Ben-Menachem E
    Epilepsia; 2004; 45 Suppl 6():13-8. PubMed ID: 15315511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to S100 proteins have anxiolytic-like activity at ultra-low doses in the adult rat.
    Castagne V; Lemaire M; Kheyfets I; Dugina JL; Sergeeva SA; Epstein OI
    J Pharm Pharmacol; 2008 Mar; 60(3):309-16. PubMed ID: 18284810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregabalin: From molecule to medicine.
    Kavoussi R
    Eur Neuropsychopharmacol; 2006 Jul; 16 Suppl 2():S128-33. PubMed ID: 16765030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice.
    Joshi I; Taylor CP
    Eur J Pharmacol; 2006 Dec; 553(1-3):82-8. PubMed ID: 17064682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
    Rodgers RJ; Gentsch C; Hoyer D; Bryant E; Green AJ; Kolokotroni KZ; Martin JL
    Behav Brain Res; 2004 Sep; 154(1):183-92. PubMed ID: 15302124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Hydroxy-2'-methoxy-6-methylflavone: a potent anxiolytic with a unique selectivity profile at GABA(A) receptor subtypes.
    Karim N; Gavande N; Wellendorph P; Johnston GA; Hanrahan JR; Chebib M
    Biochem Pharmacol; 2011 Dec; 82(12):1971-83. PubMed ID: 21924247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief post-stressor treatment with pregabalin in an animal model for PTSD: short-term anxiolytic effects without long-term anxiogenic effect.
    Zohar J; Matar MA; Ifergane G; Kaplan Z; Cohen H
    Eur Neuropsychopharmacol; 2008 Sep; 18(9):653-66. PubMed ID: 18534828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity profile of pregabalin in rodent models of epilepsy and ataxia.
    Vartanian MG; Radulovic LL; Kinsora JJ; Serpa KA; Vergnes M; Bertram E; Taylor CP
    Epilepsy Res; 2006 Mar; 68(3):189-205. PubMed ID: 16337109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic profile of pregabalin on elicited hippocampal theta oscillation.
    Siok CJ; Taylor CP; Hajós M
    Neuropharmacology; 2009 Feb; 56(2):379-85. PubMed ID: 18930748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels.
    Schuwald AM; Nöldner M; Wilmes T; Klugbauer N; Leuner K; Müller WE
    PLoS One; 2013; 8(4):e59998. PubMed ID: 23637742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic profile of girisopam and GYKI 52,322 (EGIS 6775). Comparison with chlordiazepoxide and buspirone.
    Horváth K; Andrási F; Botka P; Hámori T
    Acta Physiol Hung; 1992; 79(2):153-61. PubMed ID: 1363928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of pregabalin on psycho-motor abilities and cognitive processes in mice.
    Liliana MT; Lacramioara O; Catalina Elena L; Andra Sabina NV; Gabriela R; Gratiela P
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):185-92. PubMed ID: 25970965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
    Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
    Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.